Antihypertensive therapy in type 2 diabetes mellitus.
Miser
W F
WF
Ohio State University, Columbus, USA. miser.6@osu.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000401:mortality; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D018579:Patient Selection; D012107:Research Design
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001262:Atenolol; D002216:Captopril